Gewinn- und Verlustrechnung von Humana Inc.

SAN FRANCISCO, Oct. 6, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP is investigating potential wrongdoing at Humana Inc. (NYSE: HUM) following a court ruling that key claims in a securities fraud lawsuit against Humana and its former CEO and CFO will move forward. Current shareholders are encouraged to contact the firm here: https://www.classactionlawyers.com/humana.

Humana Inc. (NYSE: HUM) and the University of Louisville today announced the publication of a [url="]new economic impact report[/url] examining Humana's contrib

SALT LAKE CITY--(BUSINESS WIRE)--BlueWind Medical, a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi® System, a patient-centric solution for urgency urinary incontinence (UUI), today announced that Humana will provide coverage for implantable tibial neuromodulation therapy for the treatment of UUI, including the Revi System, effective October 1, 2026.Humana is the second-largest Medicare Advantage organization in the U.S., with approximately 11 million enrollees in.

Humana (NYSE: HUM - Get Free Report) and Option Care Health (NASDAQ: OPCH - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Analyst Recommendations This is a breakdown of recent

UnitedHealth is exiting select Medicare Advantage plans for 2027 as rising medical costs pressure profitability, reshaping its membership mix.

Humana already told investors in July how many members it plans to drop. What your neighbor with a surviving plan has not figured out yet is how quietly the costs on that plan changed before open enrollment closes Dec. 7.

Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Sept. 28, 2026Shareholders are encouraged to contact the firm to dis

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Barclays just pulled Humana off its neutral bench and handed it a bold new target, sending shares soaring while the rest of managed care barely blinked.

Corient Private Wealth LP lowered its stake in shares of Humana Inc. (NYSE: HUM) by 15.3% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,114 shares of the insurance provider's stock after selling 3,454 shares during the period.